Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes
- PMID: 3655659
- PMCID: PMC2188713
- DOI: 10.1084/jem.166.4.947
Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes
Abstract
The 65 kD homologous restriction factor (HRF) was isolated from normal human erythrocytes (E) by immunoadsorption using rabbit anti-human HRF. The protein was radiolabeled and incorporated into the membrane of sheep erythrocytes (Es). Es bearing HRF exhibited a markedly reduced susceptibility to reactive lysis by C5b-9. Es-HRF with 1,000-3,000 HRF molecules per cell and sensitized with rabbit IgG anti-Es also were less susceptible to lysis by human large granular lymphocytes (LGL) than untreated Es sensitized with IgG antibody. Similarly, human E of a patient with paroxysmal nocturnal hemoglobinuria (PNH), lacking HRF and sensitized with IgG antibody underwent lysis by human LGL. Lysis was abrogated by incorporation of isolated human HRF. Incorporation of human decay-accelerating factor (DAF) into sensitized Es had no effect on antibody-dependent, cell-mediated cytotoxicity. Furthermore, lysis of Es by the isolated cytolytic C9-related protein (C9RP) of human cytotoxic lymphocytes could be inhibited by cell bound human HRF. These results suggest that HRF inhibits channel formation not only by C5b-9, but also by cytotoxic lymphocytes.
Similar articles
-
Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.Biochem Biophys Res Commun. 1989 Jul 14;162(1):316-25. doi: 10.1016/0006-291x(89)91998-0. Biochem Biophys Res Commun. 1989. PMID: 2751655
-
Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.J Exp Med. 1987 Feb 1;165(2):572-7. doi: 10.1084/jem.165.2.572. J Exp Med. 1987. PMID: 2434597 Free PMC article.
-
The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection.Immunol Rev. 1988 Mar;103:87-98. doi: 10.1111/j.1600-065x.1988.tb00751.x. Immunol Rev. 1988. PMID: 3292398 Review.
-
Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.Mol Immunol. 1994 Mar;31(4):301-5. doi: 10.1016/0161-5890(94)90127-9. Mol Immunol. 1994. PMID: 8139583
-
Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.Am J Med. 1989 Sep;87(3N):22N-29N. Am J Med. 1989. PMID: 2484793 Review.
Cited by
-
Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids.Biochem J. 1990 Jan 15;265(2):471-7. doi: 10.1042/bj2650471. Biochem J. 1990. PMID: 2302178 Free PMC article.
-
Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.Immunobiology. 2011 Apr;216(4):528-34. doi: 10.1016/j.imbio.2010.08.004. Epub 2010 Aug 19. Immunobiology. 2011. PMID: 20851495 Free PMC article.
-
Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.Proc Natl Acad Sci U S A. 1988 Jan;85(1):213-7. doi: 10.1073/pnas.85.1.213. Proc Natl Acad Sci U S A. 1988. PMID: 2963326 Free PMC article.
-
Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.J Exp Med. 1989 Jun 1;169(6):2211-25. doi: 10.1084/jem.169.6.2211. J Exp Med. 1989. PMID: 2786549 Free PMC article.
-
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.J Exp Med. 1989 Sep 1;170(3):637-54. doi: 10.1084/jem.170.3.637. J Exp Med. 1989. PMID: 2475570 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous